Under the terms of the agreement, Sanofi will gain an exclusive right to first negotiation for the CNS-penetrant, VTX3232.

Pancreatic cancer is resistant to conventional therapies, but cutting-edge research may improve survival rates and patient ...

The European Commission (EC) has conditionally approved Ipsen ’s Iqirvo (elafibranor) for the treatment of primary biliary ...

New safety data shows an absence of post-injection syndrome, a rare and serious side effect of long-acting olanzapine.

Vicebio has raised $100m in a Series B funding round led by TCGX. Credit: MargJohnsonVA via Shutterstock. UK-based startup ...

The EMA CHMP has recommended approval of MSD’s KEYTRUDA for two gynaecological cancers: endometrial and cervical.

Takeda UK has announced the UK's MHRA approval of fruquintinib for adults with metastatic colorectal cancer (CRC).

The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

Zevra Therapeutics has gained FDA approval for Miplyffa (arimoclomol) to treat Niemann-Pick disease type C (NPC).

The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.

The biotech has secured $65m in a Series A funding round led by Cormorant Asset Management and other investors.

After missing primary endpoints in relapsing forms of MS, tolebrutinib has proved its efficacy in secondary progressive MS ...